Melanie Cree
Concepts (404)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polycystic Ovary Syndrome | 25 | 2024 | 176 | 12.560 |
Why?
| | Insulin Resistance | 60 | 2025 | 1201 | 10.530 |
Why?
| | Diabetes Mellitus, Type 2 | 31 | 2023 | 2512 | 3.960 |
Why?
| | Mitochondria, Muscle | 11 | 2024 | 116 | 3.680 |
Why?
| | Obesity | 29 | 2024 | 2975 | 3.530 |
Why?
| | Blood Glucose | 38 | 2025 | 2180 | 3.270 |
Why?
| | Pediatric Obesity | 11 | 2025 | 590 | 2.850 |
Why?
| | Glucose Intolerance | 11 | 2021 | 146 | 2.840 |
Why?
| | Glucose Clamp Technique | 16 | 2023 | 194 | 2.600 |
Why?
| | Muscle, Skeletal | 30 | 2024 | 1707 | 2.470 |
Why?
| | Insulin | 28 | 2025 | 2399 | 2.300 |
Why?
| | Metformin | 10 | 2021 | 329 | 2.290 |
Why?
| | Glucose Tolerance Test | 21 | 2025 | 364 | 2.260 |
Why?
| | Adolescent | 79 | 2025 | 21463 | 2.190 |
Why?
| | Testosterone | 7 | 2024 | 401 | 2.150 |
Why?
| | Fasting | 7 | 2024 | 278 | 2.030 |
Why?
| | Fatty Liver | 5 | 2024 | 242 | 2.010 |
Why?
| | Liver | 12 | 2023 | 1938 | 2.000 |
Why?
| | Triglycerides | 9 | 2022 | 524 | 1.910 |
Why?
| | Hyperandrogenism | 3 | 2024 | 21 | 1.900 |
Why?
| | Fatty Acids, Nonesterified | 7 | 2018 | 159 | 1.620 |
Why?
| | Diabetes Mellitus, Type 1 | 17 | 2024 | 3709 | 1.580 |
Why?
| | Metabolic Syndrome | 3 | 2020 | 354 | 1.530 |
Why?
| | Body Mass Index | 13 | 2025 | 2364 | 1.460 |
Why?
| | Female | 99 | 2025 | 72840 | 1.420 |
Why?
| | Burns | 9 | 2010 | 323 | 1.410 |
Why?
| | Lipolysis | 4 | 2019 | 46 | 1.360 |
Why?
| | Lipid Metabolism | 6 | 2019 | 512 | 1.360 |
Why?
| | Hyperinsulinism | 4 | 2019 | 121 | 1.310 |
Why?
| | Young Adult | 36 | 2025 | 13126 | 1.220 |
Why?
| | Child | 51 | 2025 | 21968 | 1.220 |
Why?
| | Adipose Tissue | 6 | 2022 | 629 | 1.190 |
Why?
| | Cross-Sectional Studies | 22 | 2024 | 5417 | 1.160 |
Why?
| | Magnetic Resonance Spectroscopy | 9 | 2024 | 616 | 1.140 |
Why?
| | Glycerol | 6 | 2023 | 94 | 1.140 |
Why?
| | Humans | 121 | 2025 | 136783 | 1.140 |
Why?
| | Oxidative Phosphorylation | 4 | 2019 | 193 | 1.130 |
Why?
| | Circadian Rhythm | 6 | 2025 | 465 | 1.100 |
Why?
| | Hypoglycemic Agents | 9 | 2019 | 1281 | 1.010 |
Why?
| | Glucose | 10 | 2023 | 1019 | 1.010 |
Why?
| | Body Composition | 6 | 2024 | 677 | 0.940 |
Why?
| | Insulin-Secreting Cells | 6 | 2020 | 372 | 0.940 |
Why?
| | Case-Control Studies | 15 | 2024 | 3537 | 0.910 |
Why?
| | Exercise | 12 | 2024 | 2038 | 0.880 |
Why?
| | Male | 74 | 2025 | 67361 | 0.870 |
Why?
| | Cardiovascular Diseases | 6 | 2019 | 2108 | 0.840 |
Why?
| | Androgens | 2 | 2022 | 187 | 0.820 |
Why?
| | Prediabetic State | 4 | 2021 | 253 | 0.810 |
Why?
| | Sleep Initiation and Maintenance Disorders | 2 | 2020 | 165 | 0.800 |
Why?
| | Transition to Adult Care | 1 | 2024 | 81 | 0.790 |
Why?
| | Gastrointestinal Microbiome | 2 | 2021 | 696 | 0.780 |
Why?
| | Hyperglycemia | 4 | 2021 | 346 | 0.770 |
Why?
| | Non-alcoholic Fatty Liver Disease | 3 | 2021 | 278 | 0.750 |
Why?
| | Adult | 44 | 2024 | 37616 | 0.730 |
Why?
| | Adenosine Diphosphate | 2 | 2021 | 79 | 0.720 |
Why?
| | Klinefelter Syndrome | 1 | 2021 | 61 | 0.690 |
Why?
| | Desogestrel | 1 | 2020 | 46 | 0.670 |
Why?
| | Adolescent Medicine | 1 | 2020 | 36 | 0.670 |
Why?
| | Overweight | 6 | 2025 | 557 | 0.670 |
Why?
| | Obesity, Morbid | 1 | 2024 | 258 | 0.660 |
Why?
| | Lipogenesis | 2 | 2019 | 60 | 0.660 |
Why?
| | Isotopes | 1 | 2019 | 33 | 0.640 |
Why?
| | Inservice Training | 1 | 2020 | 113 | 0.640 |
Why?
| | Endocrinology | 1 | 2020 | 79 | 0.630 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2019 | 50 | 0.610 |
Why?
| | Gluconeogenesis | 1 | 2019 | 79 | 0.610 |
Why?
| | Absorptiometry, Photon | 6 | 2024 | 253 | 0.610 |
Why?
| | Energy Metabolism | 3 | 2024 | 918 | 0.600 |
Why?
| | Obesity, Abdominal | 1 | 2018 | 48 | 0.590 |
Why?
| | Mentors | 1 | 2020 | 197 | 0.580 |
Why?
| | Gynecology | 1 | 2020 | 176 | 0.570 |
Why?
| | Interprofessional Relations | 1 | 2020 | 280 | 0.560 |
Why?
| | Adiposity | 4 | 2018 | 518 | 0.550 |
Why?
| | Mentoring | 1 | 2020 | 143 | 0.550 |
Why?
| | Sleep | 4 | 2025 | 751 | 0.540 |
Why?
| | Fenofibrate | 2 | 2007 | 28 | 0.540 |
Why?
| | Fatty Acids | 2 | 2019 | 444 | 0.540 |
Why?
| | Lipoproteins, HDL | 1 | 2017 | 77 | 0.530 |
Why?
| | Amino Acids | 3 | 2019 | 500 | 0.530 |
Why?
| | Depressive Disorder | 1 | 2020 | 380 | 0.530 |
Why?
| | Hypolipidemic Agents | 2 | 2007 | 92 | 0.520 |
Why?
| | C-Peptide | 5 | 2019 | 163 | 0.510 |
Why?
| | Biodiversity | 1 | 2020 | 404 | 0.510 |
Why?
| | Oxygen Consumption | 9 | 2024 | 696 | 0.510 |
Why?
| | Muscle Proteins | 7 | 2017 | 229 | 0.460 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 2 | 2025 | 82 | 0.460 |
Why?
| | Mitochondria | 5 | 2024 | 946 | 0.450 |
Why?
| | Severity of Illness Index | 4 | 2025 | 2831 | 0.450 |
Why?
| | Lipoproteins | 1 | 2015 | 167 | 0.440 |
Why?
| | Aging | 3 | 2019 | 1861 | 0.440 |
Why?
| | Prognosis | 5 | 2020 | 4018 | 0.430 |
Why?
| | Diabetes Mellitus | 2 | 2020 | 1033 | 0.430 |
Why?
| | Sleep Apnea, Obstructive | 2 | 2025 | 291 | 0.430 |
Why?
| | B-Lymphocytes | 1 | 2019 | 846 | 0.420 |
Why?
| | Bacteria | 1 | 2020 | 855 | 0.420 |
Why?
| | Cohort Studies | 9 | 2021 | 5718 | 0.420 |
Why?
| | PPAR alpha | 3 | 2007 | 58 | 0.410 |
Why?
| | Decision Making | 1 | 2020 | 896 | 0.410 |
Why?
| | Oxygen | 1 | 2018 | 933 | 0.410 |
Why?
| | Cardiorespiratory Fitness | 3 | 2024 | 55 | 0.400 |
Why?
| | Magnetic Resonance Imaging | 6 | 2024 | 3566 | 0.390 |
Why?
| | Bed Rest | 2 | 2009 | 14 | 0.390 |
Why?
| | Follow-Up Studies | 6 | 2020 | 5115 | 0.390 |
Why?
| | Calorimetry, Indirect | 2 | 2024 | 83 | 0.370 |
Why?
| | Risk Factors | 11 | 2021 | 10331 | 0.370 |
Why?
| | Insulin Glargine | 3 | 2019 | 84 | 0.360 |
Why?
| | Puberty | 3 | 2024 | 146 | 0.350 |
Why?
| | Cystic Fibrosis | 1 | 2020 | 1104 | 0.340 |
Why?
| | Hirsutism | 2 | 2021 | 12 | 0.330 |
Why?
| | Cushing Syndrome | 1 | 2009 | 10 | 0.330 |
Why?
| | Gastroplasty | 2 | 2021 | 30 | 0.330 |
Why?
| | Algorithms | 2 | 2021 | 1686 | 0.310 |
Why?
| | Diabetic Nephropathies | 3 | 2020 | 293 | 0.310 |
Why?
| | Middle Aged | 16 | 2024 | 33200 | 0.310 |
Why?
| | Estradiol | 3 | 2022 | 518 | 0.300 |
Why?
| | Pleural Neoplasms | 1 | 2009 | 25 | 0.300 |
Why?
| | Prospective Studies | 7 | 2020 | 7583 | 0.300 |
Why?
| | Retrospective Studies | 8 | 2024 | 15564 | 0.300 |
Why?
| | Mesothelioma | 1 | 2009 | 43 | 0.290 |
Why?
| | Sex Characteristics | 3 | 2025 | 763 | 0.270 |
Why?
| | Protein Kinase C | 1 | 2008 | 260 | 0.260 |
Why?
| | Exercise Tolerance | 4 | 2017 | 279 | 0.260 |
Why?
| | Diabetic Cardiomyopathies | 2 | 2016 | 36 | 0.250 |
Why?
| | Diabetes, Gestational | 2 | 2025 | 316 | 0.250 |
Why?
| | Autoimmunity | 1 | 2012 | 908 | 0.250 |
Why?
| | Actigraphy | 3 | 2025 | 109 | 0.240 |
Why?
| | Melatonin | 3 | 2025 | 150 | 0.230 |
Why?
| | Reproducibility of Results | 8 | 2025 | 3272 | 0.230 |
Why?
| | Biological Clocks | 1 | 2025 | 45 | 0.230 |
Why?
| | Carnitine | 3 | 2019 | 83 | 0.230 |
Why?
| | Lipoproteins, VLDL | 1 | 2024 | 18 | 0.220 |
Why?
| | Adiponectin | 2 | 2016 | 243 | 0.220 |
Why?
| | Aged | 12 | 2020 | 23729 | 0.220 |
Why?
| | Alanine Transaminase | 1 | 2024 | 157 | 0.220 |
Why?
| | Polysomnography | 1 | 2025 | 185 | 0.220 |
Why?
| | Basal Metabolism | 1 | 2024 | 60 | 0.220 |
Why?
| | Adenosine Triphosphate | 2 | 2021 | 486 | 0.210 |
Why?
| | Leg | 5 | 2021 | 236 | 0.210 |
Why?
| | Muscle Contraction | 3 | 2014 | 424 | 0.210 |
Why?
| | Age Factors | 3 | 2020 | 3290 | 0.210 |
Why?
| | Continuity of Patient Care | 1 | 2006 | 278 | 0.210 |
Why?
| | Endocrine System Diseases | 1 | 2023 | 35 | 0.210 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2024 | 212 | 0.200 |
Why?
| | Lipids | 4 | 2017 | 665 | 0.200 |
Why?
| | Muscle Strength | 2 | 2017 | 317 | 0.200 |
Why?
| | Sleep Deprivation | 1 | 2025 | 174 | 0.200 |
Why?
| | Colorado | 5 | 2020 | 4491 | 0.200 |
Why?
| | Vascular Stiffness | 2 | 2019 | 493 | 0.200 |
Why?
| | Time Factors | 6 | 2025 | 6792 | 0.200 |
Why?
| | Saliva | 2 | 2025 | 241 | 0.190 |
Why?
| | Carbon Isotopes | 4 | 2019 | 145 | 0.190 |
Why?
| | Child, Preschool | 9 | 2022 | 11069 | 0.190 |
Why?
| | Double-Blind Method | 3 | 2019 | 1981 | 0.190 |
Why?
| | Hospitalization | 2 | 2016 | 2195 | 0.190 |
Why?
| | Sex Factors | 3 | 2017 | 2068 | 0.190 |
Why?
| | Biomarkers | 6 | 2019 | 4158 | 0.180 |
Why?
| | Phosphocreatine | 1 | 2021 | 47 | 0.180 |
Why?
| | Tandem Mass Spectrometry | 1 | 2024 | 532 | 0.180 |
Why?
| | Sleep Wake Disorders | 2 | 2019 | 283 | 0.180 |
Why?
| | Incidence | 3 | 2021 | 2788 | 0.180 |
Why?
| | Transgender Persons | 1 | 2024 | 180 | 0.180 |
Why?
| | Glutathione | 1 | 2023 | 357 | 0.180 |
Why?
| | Alopecia | 1 | 2021 | 32 | 0.180 |
Why?
| | Bacteroidetes | 1 | 2021 | 24 | 0.180 |
Why?
| | Firmicutes | 1 | 2021 | 19 | 0.180 |
Why?
| | Contraceptive Devices, Female | 1 | 2020 | 10 | 0.170 |
Why?
| | Body Weight | 2 | 2019 | 981 | 0.170 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2025 | 2190 | 0.170 |
Why?
| | Sex Chromosome Disorders of Sex Development | 1 | 2020 | 16 | 0.170 |
Why?
| | Ovarian Reserve | 1 | 2020 | 16 | 0.170 |
Why?
| | Protein Biosynthesis | 2 | 2017 | 433 | 0.170 |
Why?
| | Drug Implants | 1 | 2020 | 82 | 0.170 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2020 | 38 | 0.160 |
Why?
| | Carotid Intima-Media Thickness | 2 | 2018 | 91 | 0.160 |
Why?
| | Glucose Metabolism Disorders | 1 | 2019 | 11 | 0.160 |
Why?
| | Prednisolone | 1 | 2019 | 83 | 0.160 |
Why?
| | Liraglutide | 1 | 2019 | 30 | 0.160 |
Why?
| | Device Removal | 1 | 2020 | 138 | 0.160 |
Why?
| | Aorta | 2 | 2019 | 417 | 0.160 |
Why?
| | Arginine | 2 | 2019 | 271 | 0.160 |
Why?
| | Sitagliptin Phosphate | 1 | 2019 | 33 | 0.160 |
Why?
| | Amino Acids, Essential | 2 | 2009 | 13 | 0.160 |
Why?
| | Uromodulin | 1 | 2019 | 21 | 0.150 |
Why?
| | Linear Models | 3 | 2014 | 845 | 0.150 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2019 | 141 | 0.150 |
Why?
| | Physicians, Women | 1 | 2020 | 82 | 0.150 |
Why?
| | Virilism | 1 | 2019 | 7 | 0.150 |
Why?
| | Menstruation Disturbances | 1 | 2019 | 12 | 0.150 |
Why?
| | Waist Circumference | 1 | 2019 | 143 | 0.150 |
Why?
| | United States | 3 | 2021 | 14660 | 0.150 |
Why?
| | Diastole | 1 | 2019 | 150 | 0.150 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 45 | 0.150 |
Why?
| | Sex Hormone-Binding Globulin | 1 | 2019 | 59 | 0.150 |
Why?
| | Withholding Treatment | 1 | 2019 | 76 | 0.150 |
Why?
| | Contraceptives, Oral | 1 | 2019 | 43 | 0.150 |
Why?
| | Spironolactone | 1 | 2019 | 35 | 0.150 |
Why?
| | Predictive Value of Tests | 1 | 2024 | 2030 | 0.150 |
Why?
| | Respiratory Function Tests | 1 | 2020 | 596 | 0.150 |
Why?
| | Wakefulness | 1 | 2019 | 125 | 0.150 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2021 | 549 | 0.150 |
Why?
| | Deuterium | 3 | 2015 | 98 | 0.150 |
Why?
| | Peer Group | 1 | 2020 | 244 | 0.140 |
Why?
| | Cardiotonic Agents | 1 | 2018 | 125 | 0.140 |
Why?
| | Minority Groups | 1 | 2020 | 267 | 0.140 |
Why?
| | Career Choice | 1 | 2020 | 215 | 0.140 |
Why?
| | Intra-Abdominal Fat | 1 | 2018 | 91 | 0.140 |
Why?
| | Cell Respiration | 1 | 2018 | 102 | 0.140 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2020 | 548 | 0.140 |
Why?
| | Erythrocytes | 1 | 2023 | 692 | 0.140 |
Why?
| | Spasms, Infantile | 1 | 2019 | 122 | 0.140 |
Why?
| | Alberta | 2 | 2009 | 27 | 0.140 |
Why?
| | Universities | 1 | 2020 | 432 | 0.140 |
Why?
| | Feces | 1 | 2021 | 479 | 0.140 |
Why?
| | Phosphorus Isotopes | 1 | 2017 | 7 | 0.140 |
Why?
| | Social Media | 1 | 2020 | 157 | 0.140 |
Why?
| | Blood Vessels | 1 | 2018 | 187 | 0.130 |
Why?
| | Hindlimb | 1 | 2017 | 128 | 0.130 |
Why?
| | Child Behavior | 1 | 2019 | 247 | 0.130 |
Why?
| | Kidney | 4 | 2021 | 1463 | 0.130 |
Why?
| | Affect | 1 | 2019 | 293 | 0.130 |
Why?
| | Human Development | 1 | 2016 | 16 | 0.130 |
Why?
| | Occupational Exposure | 1 | 2020 | 337 | 0.130 |
Why?
| | Placental Insufficiency | 1 | 2017 | 116 | 0.130 |
Why?
| | Regional Blood Flow | 2 | 2016 | 474 | 0.130 |
Why?
| | Hospitals, Pediatric | 2 | 2017 | 533 | 0.130 |
Why?
| | Prevalence | 2 | 2021 | 2712 | 0.120 |
Why?
| | Bone Density | 1 | 2020 | 487 | 0.120 |
Why?
| | Parenting | 1 | 2020 | 312 | 0.120 |
Why?
| | Social Support | 1 | 2020 | 615 | 0.120 |
Why?
| | Societies, Medical | 1 | 2020 | 820 | 0.120 |
Why?
| | Estrogens | 1 | 2019 | 367 | 0.120 |
Why?
| | Milk Proteins | 2 | 2006 | 34 | 0.120 |
Why?
| | Metabolome | 1 | 2019 | 350 | 0.120 |
Why?
| | Leptin | 1 | 2017 | 234 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 368 | 0.120 |
Why?
| | Drug Therapy, Combination | 1 | 2018 | 1059 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 359 | 0.120 |
Why?
| | Glucocorticoids | 1 | 2019 | 596 | 0.120 |
Why?
| | Schools | 1 | 2018 | 462 | 0.120 |
Why?
| | Life Style | 2 | 2018 | 484 | 0.110 |
Why?
| | Emergency Service, Hospital | 1 | 2006 | 2050 | 0.110 |
Why?
| | Pulse Wave Analysis | 3 | 2021 | 269 | 0.110 |
Why?
| | Phosphorus | 1 | 2014 | 97 | 0.110 |
Why?
| | Biopsy | 2 | 2008 | 1126 | 0.110 |
Why?
| | Inflammation Mediators | 1 | 2017 | 514 | 0.110 |
Why?
| | Exercise Therapy | 1 | 2018 | 434 | 0.100 |
Why?
| | Glomerular Filtration Rate | 4 | 2020 | 744 | 0.100 |
Why?
| | Metabolomics | 1 | 2019 | 679 | 0.100 |
Why?
| | Surveys and Questionnaires | 2 | 2020 | 5749 | 0.100 |
Why?
| | Echocardiography | 1 | 2016 | 659 | 0.100 |
Why?
| | Risk Assessment | 2 | 2017 | 3429 | 0.100 |
Why?
| | Area Under Curve | 3 | 2008 | 313 | 0.100 |
Why?
| | Blood Pressure | 2 | 2017 | 1772 | 0.100 |
Why?
| | Ventricular Function, Left | 1 | 2016 | 540 | 0.100 |
Why?
| | Asthma | 1 | 2006 | 2290 | 0.100 |
Why?
| | Models, Theoretical | 1 | 2015 | 572 | 0.090 |
Why?
| | Regression Analysis | 2 | 2025 | 1024 | 0.090 |
Why?
| | Models, Biological | 1 | 2019 | 1769 | 0.090 |
Why?
| | Pyruvic Acid | 2 | 2010 | 54 | 0.090 |
Why?
| | Fetal Growth Retardation | 1 | 2017 | 565 | 0.090 |
Why?
| | Emotions | 1 | 2017 | 546 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1619 | 0.090 |
Why?
| | Physicians | 1 | 2020 | 897 | 0.090 |
Why?
| | Hypoglycemia | 1 | 2016 | 443 | 0.090 |
Why?
| | Disease Progression | 2 | 2022 | 2750 | 0.090 |
Why?
| | Creatinine | 3 | 2020 | 498 | 0.090 |
Why?
| | Hypertension | 1 | 2019 | 1284 | 0.080 |
Why?
| | Treatment Outcome | 6 | 2019 | 10764 | 0.080 |
Why?
| | Genotype | 2 | 2025 | 1919 | 0.080 |
Why?
| | Internship and Residency | 1 | 2020 | 1131 | 0.080 |
Why?
| | Jet Lag Syndrome | 1 | 2019 | 14 | 0.080 |
Why?
| | Acyl Coenzyme A | 2 | 2006 | 31 | 0.080 |
Why?
| | Cohort Effect | 1 | 2009 | 5 | 0.080 |
Why?
| | Asbestos | 1 | 2009 | 37 | 0.080 |
Why?
| | Protein Kinase C beta | 1 | 2008 | 21 | 0.070 |
Why?
| | Palmitates | 1 | 2008 | 18 | 0.070 |
Why?
| | Hypertriglyceridemia | 1 | 2008 | 39 | 0.070 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2005 | 180 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2025 | 1942 | 0.070 |
Why?
| | Age Distribution | 1 | 2009 | 391 | 0.070 |
Why?
| | Sex Distribution | 1 | 2009 | 376 | 0.070 |
Why?
| | Quality Improvement | 1 | 2016 | 1152 | 0.070 |
Why?
| | Muscle Cells | 1 | 2007 | 43 | 0.070 |
Why?
| | Acetates | 1 | 2007 | 99 | 0.070 |
Why?
| | Albuminuria | 2 | 2020 | 185 | 0.070 |
Why?
| | Pregnancy | 4 | 2025 | 6731 | 0.070 |
Why?
| | Trauma Severity Indices | 1 | 2007 | 106 | 0.070 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2005 | 591 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2847 | 0.060 |
Why?
| | Phenylalanine | 4 | 2009 | 68 | 0.060 |
Why?
| | Islets of Langerhans | 1 | 2012 | 803 | 0.060 |
Why?
| | Muscular Atrophy | 1 | 2006 | 83 | 0.060 |
Why?
| | Carbon Dioxide | 1 | 2007 | 267 | 0.060 |
Why?
| | Animals | 8 | 2017 | 36768 | 0.060 |
Why?
| | Milk | 1 | 2006 | 124 | 0.060 |
Why?
| | Critical Care | 1 | 2010 | 583 | 0.060 |
Why?
| | Caseins | 1 | 2004 | 20 | 0.060 |
Why?
| | Self Report | 1 | 2019 | 825 | 0.060 |
Why?
| | Oxidation-Reduction | 1 | 2008 | 1062 | 0.060 |
Why?
| | Cystatin C | 2 | 2014 | 65 | 0.060 |
Why?
| | Albumins | 1 | 2005 | 113 | 0.060 |
Why?
| | Fibrinogen | 1 | 2005 | 168 | 0.050 |
Why?
| | Physical Exertion | 1 | 2005 | 215 | 0.050 |
Why?
| | Mitochondrial Diseases | 1 | 2024 | 91 | 0.050 |
Why?
| | Placebos | 2 | 2019 | 197 | 0.050 |
Why?
| | Stress, Physiological | 1 | 2006 | 442 | 0.050 |
Why?
| | Dietary Carbohydrates | 1 | 2003 | 154 | 0.050 |
Why?
| | Exercise Test | 3 | 2016 | 625 | 0.050 |
Why?
| | Glycolysis | 1 | 2024 | 318 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2022 | 110 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2025 | 657 | 0.050 |
Why?
| | Light | 1 | 2025 | 382 | 0.050 |
Why?
| | Ambulatory Care | 1 | 2006 | 538 | 0.050 |
Why?
| | Critical Illness | 1 | 2007 | 807 | 0.040 |
Why?
| | Registries | 1 | 2009 | 2015 | 0.040 |
Why?
| | Gonadotropins | 1 | 2020 | 40 | 0.040 |
Why?
| | Hydroxyestrones | 1 | 2000 | 2 | 0.040 |
Why?
| | Isoflavones | 1 | 2000 | 26 | 0.040 |
Why?
| | Anti-Mullerian Hormone | 1 | 2020 | 57 | 0.040 |
Why?
| | Chromosomes, Human, X | 1 | 2020 | 74 | 0.040 |
Why?
| | Sex Chromosome Aberrations | 1 | 2020 | 66 | 0.040 |
Why?
| | Salaries and Fringe Benefits | 1 | 2020 | 56 | 0.040 |
Why?
| | Parental Leave | 1 | 2020 | 26 | 0.040 |
Why?
| | Trisomy | 1 | 2020 | 82 | 0.040 |
Why?
| | Causality | 1 | 2019 | 127 | 0.040 |
Why?
| | Administration, Oral | 3 | 2006 | 808 | 0.040 |
Why?
| | Hormones | 1 | 2019 | 142 | 0.040 |
Why?
| | Sulfonylurea Compounds | 1 | 2019 | 48 | 0.040 |
Why?
| | Practice Guidelines as Topic | 2 | 2017 | 1568 | 0.040 |
Why?
| | Rats, Zucker | 2 | 2010 | 34 | 0.040 |
Why?
| | Biological Transport | 2 | 2010 | 411 | 0.030 |
Why?
| | Diabetic Angiopathies | 1 | 2019 | 258 | 0.030 |
Why?
| | Magnetic Resonance Angiography | 1 | 2018 | 240 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2009 | 7569 | 0.030 |
Why?
| | Whey Proteins | 2 | 2006 | 6 | 0.030 |
Why?
| | Physicians, Primary Care | 1 | 2018 | 232 | 0.030 |
Why?
| | Tertiary Care Centers | 1 | 2016 | 160 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2016 | 109 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2020 | 6046 | 0.030 |
Why?
| | Sheep | 1 | 2017 | 855 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1611 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1483 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2021 | 1309 | 0.030 |
Why?
| | Rabbits | 2 | 2005 | 789 | 0.030 |
Why?
| | Infant | 2 | 2019 | 9442 | 0.030 |
Why?
| | Stress, Mechanical | 1 | 2016 | 480 | 0.030 |
Why?
| | Mothers | 1 | 2020 | 752 | 0.030 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2014 | 145 | 0.030 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2014 | 204 | 0.030 |
Why?
| | Weight Loss | 1 | 2018 | 775 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2016 | 808 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2014 | 366 | 0.020 |
Why?
| | Diet | 1 | 2000 | 1273 | 0.020 |
Why?
| | Glucagon | 1 | 2012 | 109 | 0.020 |
Why?
| | Parents | 1 | 2020 | 1355 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2014 | 1513 | 0.020 |
Why?
| | Malonyl Coenzyme A | 1 | 2010 | 5 | 0.020 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2010 | 33 | 0.020 |
Why?
| | Glycogen | 1 | 2010 | 55 | 0.020 |
Why?
| | Sciatic Nerve | 1 | 2010 | 58 | 0.020 |
Why?
| | Adaptation, Physiological | 1 | 2014 | 546 | 0.020 |
Why?
| | Rats | 2 | 2010 | 5628 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2010 | 408 | 0.020 |
Why?
| | Cholesterol, VLDL | 1 | 2008 | 5 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2010 | 268 | 0.020 |
Why?
| | Lactic Acid | 1 | 2010 | 306 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2010 | 783 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 849 | 0.020 |
Why?
| | Primary Health Care | 1 | 2018 | 1714 | 0.020 |
Why?
| | Radioactive Tracers | 1 | 2007 | 3 | 0.020 |
Why?
| | Citric Acid Cycle | 1 | 2007 | 59 | 0.020 |
Why?
| | Sodium Bicarbonate | 1 | 2007 | 45 | 0.020 |
Why?
| | Breath Tests | 1 | 2007 | 87 | 0.020 |
Why?
| | Cholesterol | 1 | 2008 | 410 | 0.020 |
Why?
| | Multienzyme Complexes | 1 | 2006 | 68 | 0.020 |
Why?
| | Diglycerides | 1 | 2006 | 61 | 0.020 |
Why?
| | Palmitoylcarnitine | 1 | 2005 | 1 | 0.020 |
Why?
| | Methods | 1 | 2005 | 65 | 0.020 |
Why?
| | Carbohydrate Sequence | 1 | 2005 | 27 | 0.020 |
Why?
| | Palmitic Acid | 1 | 2005 | 41 | 0.020 |
Why?
| | Reference Standards | 1 | 2005 | 183 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2006 | 313 | 0.010 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2006 | 197 | 0.010 |
Why?
| | Metabolic Clearance Rate | 1 | 2005 | 116 | 0.010 |
Why?
| | Weight Lifting | 1 | 2004 | 34 | 0.010 |
Why?
| | Dietary Supplements | 1 | 2008 | 559 | 0.010 |
Why?
| | Leucine | 1 | 2004 | 111 | 0.010 |
Why?
| | Hydrocortisone | 1 | 2006 | 317 | 0.010 |
Why?
| | Fluorocarbons | 1 | 2005 | 117 | 0.010 |
Why?
| | Patient Discharge | 1 | 2010 | 896 | 0.010 |
Why?
| | Phenotype | 1 | 2012 | 3199 | 0.010 |
Why?
| | Chromatography, Liquid | 1 | 2005 | 432 | 0.010 |
Why?
| | Heart Rate | 1 | 2007 | 823 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2006 | 1318 | 0.010 |
Why?
| | Blood Proteins | 1 | 2005 | 249 | 0.010 |
Why?
| | Phosphorylation | 1 | 2006 | 1756 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2005 | 2145 | 0.010 |
Why?
| | Motor Activity | 1 | 2006 | 719 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2005 | 2903 | 0.010 |
Why?
| | Neoplasms, Hormone-Dependent | 1 | 2000 | 38 | 0.010 |
Why?
| | Premenopause | 1 | 2000 | 131 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2005 | 2603 | 0.010 |
Why?
| | Signal Transduction | 1 | 2006 | 5065 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2000 | 2239 | 0.000 |
Why?
|
|
Cree's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|